This inhibition has been a major obstacle for dispensaries and other cannabis-related businesses, but the use of bitcoin technology could be the key to overcoming the roadblock.
Cannabis News
India Globalization Capital’s (NYSE: IGC) Cannabis Drug Development for Alzheimer’s Backed by Previous Studies
Its drug development pipeline consists of treatments for seizures, neuropathic pain, and eating disorders, but one gaining attention is an experimental cannabis-based drug for Alzheimer’s disease, IGC-AD1.
Industry Movers Riding the Wave of Bitcoin’s Increasing Value
Bitcoin’s recent climb above the $4,500 mark is just one example of how its market capitalization continues to gain unprecedented reach. (http://nnw.fm/lGp8V) From cannabis to technology, bitcoin has impacted industries far and wide, but analysts believe that the cryptocurrency isn’t done climbing.
InMed Pharmaceuticals, Inc. (IMLFF) Gains Attention for Its Operational Developments and Leadership Team
InMed Pharmaceuticals, Inc. (OTCQB: IMLFF), a pre-clinical stage biopharmaceutical company that specializes in the development of therapies through research and development into the pharmacology of cannabinoids and drug delivery systems, continues to get positive media coverage of ongoing operational developments, propelled by the company’s impressive leadership team.
Biotech Players Lead the Growth Charge in the Legal Cannabis Market
The backbone of medical advancement is biotechnology, an industry wrought with the incredible potential of novel drug R&D, but vulnerable to the risk of stringent regulatory approval processes. Within this volatile market, however, is the cannabis-biotech sub-sector – a market flourishing with opportunity, innovation, and deep roots of medical possibilities.
Senate Appropriations Committee Action Adds Fuel to the Fire for Businesses in the Legal Cannabis Space
Proponents of legal cannabis celebrated a victory on July 27. By voice vote, the Senate Appropriations Committee approved a budget bill amendment that prevents the federal government from interfering in medical marijuana programs in states where cannabis has been legalized for medical use1.
Medical Marijuana, Inc. Subsidiary Kannaway® Announces July 25, 2017 Largest Revenue Day in Company History
Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that its subsidiary Kannaway® achieved the largest revenue in a single day on July 25, 2017 , in the Company's history. Kannaway® is the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products.
Canopy Accelerator Invests $1,000,000 in Cannabis Tech Startups in 2017
Canopy , a venture fund and business accelerator for companies developing ancillary products and services for the legal cannabis industry, is pleased to announce the launch of its Fall 2017 class in Boulder, Colorado .
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Moves Closer to Kimmett Expansion with TSXV Approval of Cannabis Wheaton Investment
Cannabis Wheaton Income Corp. (TSX.V: CBW) this morning announced that it has received approval from the TSX Venture Exchange to purchase $15 million of common shares of ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF) at an agreed upon valuation of $2.25 per share.
Marijuana Company of America Completes $250,000 Investment in MoneyTrac Technology
MARIJUANA COMPANY OF AMERICA, INC. (OTC PINK: MCOA), an innovative cannabis and hemp corporation, is pleased to announce that it has completed an investment of $250,000 into MoneyTrac Technology, Inc. ("MTT"), a subsidiary of Global Payout, Inc. (OTC PINK: GOHE), in exchange for a 15% ownership interest.
Isodiol International Inc. Announces Unaudited Quarterly Profit of Iso International LLC
Isodiol International Inc. (CSE:ISOL) (OTC:LAGBF) (Frankfurt:LB6A.F) a global cannabis innovator, specializing in the development of pharmaceutical and consumer products, announces the operational numbers of its wholly-owned subsidiary for the period from April 1, 2017 to June 30, 2017.
Investment Options in the Multi-billion Dollar Medical Marijuana Industry
Mounting research from around the world suggests marijuana's potential to treat multiple medical conditions ranging from chronic pain to cancer, epilepsy, HIV/AIDS, anxiety and more.
Tecogen Makes First Sale into Florida's Indoor Grow Facility Industry
Tecogen® Inc. (NASDAQ: TGEN), a clean energy company providing ultra-efficient, clean, natural gas-powered on-site power, heating and cooling equipment, is pleased to announce the sale of three of its Tecochill "STx Series" chillers to an indoor cannabis growing operation near Tampa, FL. This marks Tecogen's first sale into Florida's recently legalized medical marijuana business.
OWC Pharmaceutical Research Corp Appoints Dr. Stanley Hirsch as its Active Chairman
OWC Pharmaceutical Research Corp. (OTCQB: OWCP), ("OWC" or the "Company"), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced the appointment of Dr. Stanley Hirsch as its active chairman of the board of directors.
Aurora Cannabis : Starts Trading on Toronto Stock Exchange
Aurora Cannabis Inc. (the "Company" or "Aurora") (TSXV: ACB) (OTCQX: ACBFF) ( Frankfurt : 21P; WKN: A1C4WM) announced today that common shares of the Company will commence trading on Toronto Stock Exchange (the "TSX") effective Monday July 24 . Common shares will continue to trade under the symbol "ACB".